Final ID: P-436
Gangeddula Vishwaas, Mankan Kanita, Asawaroekwisoot Thanin, Kim Seonghyeon, Liu Yangjiayi, Lapadjyan Mary, Shahnazarian Christine, Massihians Monique, Park David, Ho Meghan, Ghaffarian Bahaar, Yongkiatkan Panchanit, Sibia Gurleen, Le Vanessa, Lee Sarah, Vutthikraivit Possawat, Bunyawannukul Issaree, Kookanok Chutawat, Kulthamrongsri Narathorn, Wattanachayakul Phuuwadith, Lee Kyunghee, Tantisattamo Ekamol, Wongmat Napat, Wareesawetsuwan Nicha, Puyati Weerinth, Chamnarnphol Natanon, Noree Wanprapit, Mohpichai Nopavit, Ngaohirunpat Sorawis
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor